Efficacy and safety of 88% phenol application versus cryotherapy in repigmentation of idiopathic guttate hypomelanosis: A comparative study
Keywords:
Idiopathic guttate hypomelanosis, 88% phenol, cryotherapyAbstract
Background Idiopathic guttate hypomelanosis (IGH) is a common, acquired dermatosis characterized by multiple, round or oval, hypopigmented to depigmented macules. A variety of therapies with variable success are described, despite that, the treatment remains still unsatisfactory and therapeutic challenge for dermatologists. Objective The objective of this study is to compare the safety & efficacy of 88% phenol application & cryotherapy in repigmentation of IGH macules. Materials and Methods A total of 30 patients with more than 10 IGH macules were selected. For each enrolled patient 88% phenol was applied to 5 IGH macules and single cryotherapy for 3-5 seconds was applied for another 5 IGH macules once in a month till the repigmentation for maximum of 3 applications. Patients were assessed monthly for 3 months for the side effects and improvement in pigmentation. The degree of improvement in pigmentation was assessed using a grading system, <25%- no response (grade-1), 26-50% minimal (grade-2), 51-75% good (grade-3) and >75% excellent response (grade-4). Results A total of 25 patients completed the study. At the end of the treatment period, out of 125 macules treated with short contact cryotherapy 75(60%) macules showed excellent response & 20(16%) macules showed good response. In phenol group, out of 125 macules 37(29.6%) & 29(23.2%) macules showed excellent & good improvement in pigmentation respectively, with p-value<0.05. Side effects like persistent scabbing, ulceration were more common with 88% phenol application compared to cryotherapy. Conclusion Short contact cryotherapy of 3-5 seconds was found to be more efficacious and safe compared to therapeutic wounding with 88% phenol in inducing pigmentation of IGH macules.ÂReferences
Shin MK, Jeong KH, Oh IH, Choe BK, Lee MH (2011) Clinical features of idiopathic guttate hypomelanosis in 646 subjects and association with other aspects of photoaging. Int J Dermatol 2011; 50: 798-805.
Ortonne JP, Perrot H (1980) Idiopathic guttate hypomelanosis. Ultrastructural study. Arch Dermatol 1980; 116: 664-68.
Kim SK, Kim EH, Kang HY, Lee ES, Sohn S, Kim YC. Comprehensive understanding of idiopathic guttate hypomelanosis: Clinical and histopathological correlation. Int J Dermatol. 2010; 49: 162–66.
Lapeere H, Boone B, Schepper SD, Verhaeghe E, Ongenae K, Geel NV. Hypomelanoses and hypermelanoses. In: Wollf K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Dermatology in General Medicine. 7th ed. New York: Mc Graw-Hill; 2008. p. 630.
Costa OG. Progressive symmetrical leukopathia of the extremities. Ann Dermatol Syphiligr. 1951; 78: 452-54.
Cummings KI, Cottel WI. Idiopathic guttate hypomelanosis. Arch Dermatol 1966; 93: 184-86.
Arrunategui A, Trujillo RA, Marulanda MP, Sandoval F, Wagner A, et al. HLA-DQ3 is associated with idiopathic guttate hypomelanosis, whereas HLA-DR8 is not, in a group of renal transplant patients. Int J Dermatol 2002; 41:744-47.
Kumarasinghe SP. 3-5 second cryotherapy is effective in idiopathic guttate hypomelanosis. J Dermatol 2004; 31: 437-39.
Ankad BS, Beergouder SL. Dermoscopic evaluation of idiopathic guttate hypomelanosis: A preliminary observation. Indian Dermatol Online J. 2015; 6: 164-167.
Ravikiran SP, Sacchidanand S, Leelavathy B. Therapeutic wounding - 88% phenol in idiopathic guttate hypomelanosis. Indian Dermatol Online J 2014; 5: 14-18.
Ploysangam T, Dee-Analap S, Suvanprakorn P: Treatment of idiopathic guttate hypomelanosis with liquid nitrogen: Light and electron microscopic studies, J Am Acad Dermatol. 1990; 23: 681–84.
Falabella R, Escobar C, Giraldo N, Rovetto P, Gil J, Barona MI, et al. On the pathogenesis of idiopathic guttate hypomelanosis. J Am Acad Dermatol 1987; 16: 35-44.
Shin J, Kim M, Park SH, Oh SH. The effect of fractional carbondioxide lasers on idiopathic guttate hypomelanosis: A preliminary study. J Eur Acad Dermatol Venereol. 2013; 27: 243-6.